Abstract
Biobanking and its associated policies and procedures for managing biological specimen collections are critical to the success of a variety of research endeavors. Several international organizations have produced best practices which cover the important technical and ethical-regulatory issues that are important for the collection and management of biospecimens and associated data. The expanding and global nature of biomedical research has resulted in disparities in biobanking practices among high-income countries (HIC) and low- and middle-income countries (LMIC). In Africa, projects such as H3Africa and B3Africa have resulted in new and promising advances in biobanking infrastructure and the creation of biobanking networks. However, the initiation of such projects has highlighted some of the challenges faced by biobanks in Africa, from both the technical and ethical-regulatory perspectives.
This chapter was originally published in “The State of Oncology Africa, 2015” which was published and distributed by the International Prevention Research Institute of 95 cours Lafayette, Lyon France under ISBN 978-953-9268-3-5, in 2016.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
Biobanking and biobanks may also be referred to as biorepositories, biological resources or biological resource centers (BRC).
- 2.
Biological specimens or biospecimens can be solid tissues, fluids e.g. blood, urine, saliva.
References
Armed Forces Institute of Pathology. http://www.nlm.nih.gov/hmd/medtour/afip.html. Accessed 20 Apr 2016
Doll R, Smith PG (1982) Comparison between registries: age-standardized rates. In: JAH W, Muir CS (eds) Cancer incidence in five continents, vol IV. IARC Scientific Publication No. 42, Lyon, pp 671–675
Vaught J (2016) Biobanking comes of age: the transition to biospecimens science. Annu Rev Pharmacol Toxicol 56:211–228
Hewitt SM, Badve SS, True LD (2012) Impact of preanalytic factors on the design and application of integral biomarkers for directing patient therapy. Clin Cancer Res 18:1524–1530
Vaught J (2015) Developments in biospecimen research. Br Med Bull 2015:1–10
Moore HM, Compton CC, Alper J, Vaught JB (2011) International approaches to advancing biospecimen science. Cancer Epidemiol Biomark Prev 20:729–732
International Society for Biological and Environmental Repositories (ISBER). http://www.isber.org. [Accessed 20 April 2016]. ISBER Strategic Plan 2014–2017. http://c.ymcdn.com/sites/www.isber.org/resource/resmgr/documents/ISBER_2014-2017_Summary_Oper.pdf. Accessed 20 Apr 2016
European, Middle Eastern and African Society for Biopreservation and Biobanking (ESBB). http://www.esbb.org. Accessed 20 Apr 2016
BBMRI-ERIC. http://bbmri-eric.eu/. Accessed 20 Apr 2016
BCNet, The Low- and Middle-Income Countries (LMICs) Biobank and Cohort Building Network. http://bcnet.iarc.fr/ Accessed 20 Apr 2016
Catholic University Lyon, Masters Program in Biobank Management. http://www.estbb.fr/ Accessed 20 April 2016
Vaught J, Bledsoe M, Watson P (2014) Biobanking on multiple continents: will international coordination follow? Biopreserv Biobank 12:1–2
Vaught J, Abayomi A, Peakman T et al (2014) Critical issues in international biobanking. Clin Chem 60:1368–1374
Vaught J, Rogers J, Carolin T, Compton C (2011) Biobankonomics: developing a sustainable business model approach for the formation of a human tissue biobank. J Natl Cancer Inst Monogr:24–31
Engel KB, Vaught J, Moore HM (2014) National cancer institute biospecimen evidence-based practices: a novel approach to pre-analytical standardization. Biopreserv Biobank 12:148–150
Vaught JB, Lockhart N, Thiel KS, Schneider JA (2007) Ethical, legal, and policy issues: dominating the biospecimen discussion. Cancer Epidemiol Biomark Prev 16:2521–2523
Forsberg JS, Hansson MG, Eriksson S (2009) Changing perspectives in biobank research: from individual rights to concerns about public health regarding the return of results. Eur J Hum Genet 17:1544–1549
Office of Human Research Protections (OHRP, US Dept of Health and Human Services). OHRP Basic Elements of Informed Consent. http://www.hhs.gov/ohrp/policy/faq/informed-consent/basic-elements-of-informed-consent.html. Accessed 20 Apr 2016
European Data Protection Reform. http://ec.europa.eu/justice/data-protection/reform/index_en.htm. Accessed 20 Apr 2016
International Agency for Research on Cancer. Common Minimum Technical Standards and Protocols for Biological Resource Centres dedicated to Cancer Research. http://www.iarc.fr/en/publications/pdfs-online/wrk/wrk2/index.php. Accessed 20 Apr 2016
Vaught J, Lockhart NC (2012) The evolution of biobanking best practices. Clinica Chim Acta 413:1569–1575
Vaught JB, Caboux E, Hainaut P (2010) International efforts to develop biospecimen best practices. Cancer Epidemiol Biomark Prev 19:912–915
U.S. National Cancer Institute Best Practices for Biological Resources. http://biospecimens.cancer.gov/bestpractices/. Accessed 20 Apr 2016
Rebbeck T (Ed) 2013 Handbook for Cancer Research in Africa. WHO Regional Office for Africa
Vaught J (2013) Economics: the neglected “omics” of biobanking. Biopreserv Biobank 11:259
Henderson M, Simeon-Dubach D, Albert M (2015) Finding the path to biobank sustainability through sound business planning. Biopreserv Biobank 13:385–386
Mendy M, Caboux E, Sylla B, Dillner J, Chinquee J, Wild C (2014) BCNet survey participants. Infrastructure and facilities for human biobanking in low- and middle-income countries: a situation analysis. Pathobiology 81:252–260. doi:10.1159/000362093
The Gambia West Africa Medical Research Council Unit. http://www.mrc.gm/research-sites/fajara/. Accessed 20 Apr 2016
Sirugo G, van der Loeff M S, Sam O, Nyan O, Pinder M, Hill AV, Kwiatkowski D, Prentice A, de Toma C, Cann HM, Diatta M, Jallow M, Morgan G, Clarke M, Corrah T, Whittle H, McAdam K (2004 Aug) A national DNA bank in the Gambia, West Africa, and genomic research in developing countries. Nat Genet 36(8):785–786
Human Health and Heredity in Africa (H3Africa). http://www.h3africa.org/. Accessed 20 Apr 2016
Abayomi A, Christoffels A, Grewal R et al (2013) Challenges of biobanking in South Africa to facilitate indigenous research in an environment burdened with human immunodeficiency virus, tuberculosis, and emerging noncommunicable diseases. Biopreserv Biobank 11:347–354
BBMRI-ERIC B3Africa. http://bbmri-eric.eu/b3africa. Accessed 20 Apr 2016
Boyle P, Sullivan R, Zielinski C, Brawley O, Editors. The State of Oncology 2013. International Prevention Research Institute 2013
Fleming K (2013) Lack of pathology in lower income countries. In: Boyle P, Sullivan R, Zielinski C, Brawley OW (eds) State of oncology. iPRI, Lyon, France
Pasterk M, Zatloukal K (2013) Biobanks: central importance and standards. In: Boyle P, Sullivan R, Zielinski C, Brawley OW (eds) State of oncology. iPRI, Lyon, France
European Prospective Investigation into Cancer and Nutrition (EPIC). http://epic.iarc.fr/. Accessed 20 Apr 2016
BBMRI-ESBB HandsOnBiobank. http://handsonbiobanks.org/. Accessed 20 Apr 2016
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Vaught, J. (2017). Biobanking in Africa: Opportunities and Challenges. In: Hainaut, P., Vaught, J., Zatloukal, K., Pasterk, M. (eds) Biobanking of Human Biospecimens. Springer, Cham. https://doi.org/10.1007/978-3-319-55120-3_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-55120-3_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-55118-0
Online ISBN: 978-3-319-55120-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)